HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$1.10
Day range
$1.11 - $1.12
Year range
$0.77 - $3.54
Market cap
4.86M USD
Avg Volume
3.71K
P/E ratio
5.49
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 10.27M | 4.55% |
Operating expense | 5.20M | -2.00% |
Net income | 468.00K | 33.33% |
Net profit margin | 4.56 | 27.73% |
Earnings per share | — | — |
EBITDA | 926.00K | -10.18% |
Effective tax rate | 0.69% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.81M | -49.75% |
Total assets | 12.14M | -23.52% |
Total liabilities | 26.75M | -16.10% |
Total equity | -14.60M | — |
Shares outstanding | 4.38M | — |
Price to book | -0.08 | — |
Return on assets | 17.37% | — |
Return on capital | -54.80% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 468.00K | 33.33% |
Cash from operations | -58.00K | -105.12% |
Cash from investing | -28.00K | 56.92% |
Cash from financing | -600.00K | -100.00% |
Net change in cash | -686.00K | -189.32% |
Free cash flow | -54.75K | -104.42% |
About
Founded
1986
Headquarters
Website
Employees
108